Dynasil Corp. of America develops, manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through the following three segments: Optics, Innovation & Development and Biomedical. The Optics segment encompasses four business units – Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation, a medical technology incubator which owns rights to certain early-stage medical technologies. The Innovation & Development segment consists of the Radiation Monitoring Devices, Inc. business unit, which is among the largest small business participants in the U.S. government-funded research. The company was founded on October 20, 1960 and is headquartered in Concord, MA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company